Management of...
Transcript of Management of...
Management of Osteoarthritis of the
Hip and Knee
Mr. Lee Woo Guan
MBBS (UM)
MMed(Surgery) Sing, FRCS(Edin)
Osteoarthritis
• Most common joint disorder
• > 65 years - majority have radiographic evidenc
• > 65 years - 11% have symptomatic OA of the knee
Classification
• Primary
• Secondary - has a cause
• OA knee - primary, genetic?, > females
• OA hip - secondary (Orientals)
Dysplastic Hip
Post meniscectomy OA knee
Management
• Medical
• Surgical
Management: Medical
• Non-Pharmacological
- Patient education
- Social support
- Physiotherapy / Exercise
• Pharmacological
- Analgesics
- NSAIDs
- COX-2 inhibitors
- Topical treatment
- Intraarticular therapy
Management: Medical
• Non-Pharmacological
- Patient education- Social support
- Physiotherapy / Exercise
• Pharmacological
- Analgesics
- NSAIDs
- COX-2 inhibitors
- Topical treatment
- Intraarticular therapy
Weight reduction
• Effective in all stages
• 3 kg load across knee per kg weight
• 5 kg 5% reduction of risk for OA
• SF 36-measurement of
quality of life
Wt loss 6 min walk
SF-36
Diet 5.7% 2.8%
Exercise 2.6% 9.3%
Diet+exercise
4.4%% 12.2%
Highest
Patient Education
• Disease and management, wt. reduction, exercise
• 20% of cases as effective as NSAIDs in reducing pain but not in disability
• Synergestic effect with NSAIDs
Management: Medical
• Non-Pharmacological
- Patient education
- Social support
- Physiotherapy / Exercise
• Pharmacological
- Analgesics
- NSAIDs
- COX-2 inhibitors
- Topical treatment
- Intraarticular therapy
Social Support
• Regular phone call from a healthcare worker
• Education of family members
Management: Medical
• Non-Pharmacological
- Patient education
- Social support
- Physiotherapy / Exercise
• Pharmacological
- Analgesics
- NSAIDs
- COX-2 inhibitors
- Topical treatment
- Intraarticular therapy
Physiotherapy/Exercise
• Mainstay of treatment
• Definite improvement of pain and disability
• Traditional belief - patients concerned that joint use will “wear out” a damaged joint that is already “worn out” - NOT true for moderate intensity exercises
Physiotherapy/Exercise
• Goals
- Maintain Range of Motion
- Muscle strength
- Aerobic conditioning
(general/cardiovascular health)
Physiotherapy/Exercise
• Joint motion is chondroprotective
Cartilage needs compression / decompression
for nutrition and repair
• Increased osteophytes in those who stopped running?
• Improved aerobic capacity increases well-being, reduces depression and anxiety
Exercise
• Aerobic vs Strentherning
• Pain relief and functional improvement-
equally effective
Decrease depressive symptoms-only in aerobic exercise
Aerobic Exercises
• 15 minutes of aerobic activity at least three times a week, and then gradually build up to 30 minutes daily.
• The activity also should include at least 5 to 10 minutes of warm-up plus 5 to 10 minutes of cool-down.
walking, swimming, low-impact aerobic dance, skiing and biking, and may even include such daily activities as mowing the lawn, raking leaves or playing golf
Physiotherapy/Exercise
• Examples:
- walking (good shoe wear)
- swimming
- stationary bicycling
- quads strengthening with weights
Walking Aids
• A cane can reduce hip loading by 20-30%
• Cane handle should reach patient’s proximal wrist crease when patient is standing with arms at the side
• Held on unaffected side of body
Weight Reduction
• Longitudinal association between obesity and OA
Management: Medical
• Non-Pharmacological
- Patient education
- Social support
- Physiotherapy / Exercise
• Pharmacological
- Analgesics- NSAIDs
- COX-2 inhibitors
- Topical treatment
- Intraarticular therapy
Analgesics
• Paracetamol - first line
safe and effective
• Tramadol
• Opioids - eg. Codeine
short periods, for exacerbations
long use - constipation and risk of
falling in elderly
Management: Medical
• Non-Pharmacological
- Patient education
- Social support
- Physiotherapy / Exercise
• Pharmacological
- Analgesics
- NSAIDs- COX-2 inhibitors
- Topical treatment
- Intraarticular therapy
NSAIDs
• Effective
• Can reduce dose when used concurrently with paracetamol
• Side effects:
peptic ulcer disease
renal toxicity
hepatic toxicity
NSAIDs: Peptic Ulcer Disease
• 20-30% of hospital admissions and deaths from peptic ulcer disease in elderly
• The medicine may be worse than the disease
• Per rectal forms not safer
• With H2 blockers only reduces duodenal ulceration
• With Omeiperazole - more protective
NSAIDs: Peptic Ulcer Disease
Caution in patients:
• > 65 yrs
• h/o peptic ulcer disease
• concomitant treatment with steroids and anticoagulants
• Smokers
• CVS disease
• Heavy alcohol drinkers
NSAIDS: Renal Toxicity
Caution in:
• > 65 years
• Hypertension
• CCF
• concomitant use of diuretics
NSAIDs: Recommendations
• Short courses
• Minimal effective dose
• Toxicity in increasing order:- ibuprofen
- diclocenac
- aspirin
- naproxen
- indomethacin
- ketoprofen
- piroxicam
Management: Medical
• Non-Pharmacological
- Patient education
- Social support
- Physiotherapy / Exercise
• Pharmacological
- Analgesics
- NSAIDs
- COX-2 inhibitors- Topical treatment
- Intraarticular therapy
COX-2 Inhibitors
• Rofecoxib, Celecoxib
• Reduce GIT events
• Still can have dyspepsia, diarrhoea, abdominal pain
Oral Chondroprotective Agents
• Chondroitin and Glucosamine compounds
(Viatril S)
• Does not modify structure
• May have analgesic and anti-inflam. effects
• Exaggerated effects? - small trials flawed in design with small no. of patients
• Need large trials without company interference
Management: Medical
• Non-Pharmacological
- Patient education
- Social support
- Physiotherapy / Exercise
• Pharmacological
- Analgesics
- NSAIDs
- COX-2 inhibitors
- Topical treatment- Intraarticular therapy
Topical Treatment
• Topical NSAIDs / Capsaicin
• cannot tolerate systemic therapy
• inadequate pain relief with systemic therapy
• adjunctive in exacerbations
• better than placebo
Management: Medical
• Non-Pharmacological
- Patient education
- Social support
- Physiotherapy / Exercise
• Pharmacological
- Analgesics
- NSAIDs
- COX-2 inhibitors
- Topical treatment
- Intraarticular therapy
Intraarticular Therapy: Corticosteroids
• Last several months
• Potential for accelerated cartilage damage
Intraarticular Therapy: Hyaluronic acid
• Hyalgan
• equivalent to intraarticular corticosteroids but with greater duration of action
• equivalent to oral NSAIDs
• SYNVISC is an elastic and viscous fluid that is made from a substance called hyaluronan that is found in normal joint fluid. Hyaluronan acts as a "shock absorber" and lubricant in your knee joint
Surgery
• Arthroscopic debridement
• High tibial osteotomy
• Unicompartmental knee arthroplasty
• Total knee arthroplasty
Arthroscopic Debridement
• one of the goals -delay need for TKR
• Safe
• Debridement of degenerated meniscus tear and removal of loose body
Chondral defect
Microfracture
Autologous chondrocyte transplant
• age 15 to 50 years; and
• focal articular cartilage defect on a load bearing surface size of defect is a minimum of 1 cm2; AND
• body Mass Index (BMI) of < 35; AND
• disabling pain and/or knee locking; AND
• no active inflammatory or other arthritis, clinically and by X-ray; AND
• failure of conservative therapy, and other traditional surgical interventions, such as abrasion, drilling and microfra
Autologous chondrocyte transplant
Autologous chondrocyte transplant
Autologous chondrocyte transplant
Autologous chondrocyte transplant
High Tibial Osteotomy
• Role controversial because of good results with TKR
• Survival 85% at 5 years
• Can convert to TKR
• Alternative in young with malignment
OSTEOTOMY
Medial wedge osteotomies
Opening Wedge Osteotomies
Opening Wedge Osteotomies
Unicompartmental Knee Arthroplasty
• New TREND
• Middle aged
UKR
TKR: Indications
• Pain
- significantly affecting daily life
- complications to medical therapy
- rest pain, affecting sleep
• Deformity?: progressive and threatens outcome of arthroplasty
TKR
TKR
POST OP XRAYS
TKR COMPONENTS
TKR COMPONENTS
Computer Assisted TKR
Alignment
Implant Planning
Real time implant information
TKR: Absolute Contraindications
• Recent knee sepsis
• Remote source of ongoing infection
• Extensor mechanism discontinuity
• Recurvatum deformity secondary to muscular weakness
Hip Resurfacing
Total Hip Replacement
The Future
• Tissue culture - autologous chondrocytes cultured in vitro and reintroduced into joint
• Inhibition of collagenolytic enzymes
eg. Doxycycline
• Gene therapy - cartilage strength
Summary Medical
• Non-Pharmacological
- Patient education
- Social support
- Physiotherapy / Exercise
- Walking aids / Weight
• Pharmacological
- Analgesics
- NSAIDs
- COX-2 inhibitors
- Topical treatment
- Intraarticular therapy
Surgical
• Arthroscopic debridement
• Osteotomy
• Joint replacement
Thank you